Coming soon

Abstract submission opens in December 2026

You can already prepare: read the submission guidelines and find the right topic for your abstract below. If you would like to apply for a conference fellowship or an Early Career Award, you do this during abstract submission.
Submission opens
December 2026
Deadline: Thursday, February 4, 2027, 23:59 CET
Results: by the beginning of April 2027

How abstracts are selected

Experts in each topic peer-review all abstracts and rank them on scientific merit. The Scientific Programme Committee uses these rankings to build the scientific programme and assigns each accepted abstract to a plenary, concurrent or poster session.

Three ways your abstract can be accepted

Oral presentation
In person
You give your talk in person at the conference. The talk is also streamed live, recorded and made available on demand on the virtual conference platform.
Hybrid poster
In person + online
You present your poster in person during one of the “Poster Viewing with Authors” sessions, and you also upload a PDF of the poster to the virtual conference platform.
E-poster
Online
You upload your poster as a PDF to the virtual conference platform. You must register for the conference and can choose to attend in person or online.
The format depends on your abstract’s score and on the presentation preference you select during submission. Your acceptance email tells you which format you have been given.

Rules to know before you submit

  • You can be presenting author of only one abstract, but co-author of any number of abstracts.
  • Several submissions with the same presenting author are rejected automatically.
  • Identical abstracts submitted by different first authors are rejected automatically.
  • Abstracts without results or without a clear structure are rejected.
  • Your abstract is published in the online supplement of the European Journal of Human Genetics after the conference, but only if it is presented at the conference (in person or online).
  • By submitting, you agree that the organiser stores and uses your personal data to process your submission, to enable your presentation and to publish your abstract.
Press releases. Abstracts of particular interest to the media may be chosen for a press release. If yours is selected, the Society’s media consultant will contact you. Work that has already been published cannot be considered for a press release.

Abstract topics: where does my abstract fit?

Advances in human genetics have blurred the old borders between clinical genetics, cytogenetics and molecular genetics, and between research on monogenic and complex disorders. The topics below reflect this. They also help us find the right expert reviewers for your abstract.

Disease topics (1–12)

These cover every aspect of the conditions named, whether clinical, cytogenetic or molecular, from basic research to diagnosis and treatment.
  1. Cancer Genetics
  2. Reproductive Genetics
  3. Prenatal Genetics
  4. Sensory Disorders (Eye, Ear, Pain)
  5. Internal Organs and Endocrinology
  6. Skeletal, Connective Tissue, Ectodermal and Skin Conditions
  7. Cardiovascular Conditions
  8. Inborn Errors of Metabolism
  9. Immunology and Hematopoietic System
  10. Intellectual Disability
  11. Neurogenetic and Psychiatric Conditions
  12. Neuromuscular Conditions

Cross-cutting topics (13–26)

  1. Multiple Malformation/Anomalies Syndromes complex syndromes and cytogenetic disorders with multiple symptoms.
  2. Cytogenetics, Genome Variation and Architecture genomic variation and genome structure not necessarily linked to a specific phenotype (e.g. splicing mechanisms, origin of ring chromosomes), and studies of chromosome and genome architecture.
  3. Bioinformatics, Statistical Methods and AI bioinformatics, machine learning and statistical approaches in genomics and other -omics.
  4. Large-Scale Genomics (GWAS) and Other -Omics Association Studies the genetics of complex diseases and traits, GWAS results for rare and common variation, functional follow-up of GWAS, and large-scale association studies based on other -omics data such as metabolomics or proteomics.
  5. Genetic Epidemiology (e.g. Mendelian Randomization) the role of genomics and other -omics in personalised medicine, epidemiology and public health, and improved methods for these studies, including Mendelian randomization.
  6. Pharmacogenomics and Drug Repurposing the genetics and genomics of (adverse) drug response, and repurposed or off-label use of existing drugs for (common) genetic diseases. Drug repurposing for a specific rare disease may fit better in topic 24.
  7. Population Genetics and Evolutionary Genetics population and evolutionary genetics.
  8. Genomics of Rare Diseases work relevant to a range of rare diseases rather than one phenotype (as in topics 1–12), e.g. new technologies for rare disease research and diagnostics, or cohort-level analyses of larger, mixed groups of rare diseases.
  9. Wet & Dry Lab Improvements for Diagnostics technical approaches and quality control in genetic diagnostics and research.
  10. Functional Genomics the biology and function of the genome, including epigenetics.
  11. New Technologies brand-new concepts or genomic technologies and the evaluation of their potential.
  12. Treatments for Genetic Disorders novel therapeutic opportunities for genetic disorders.
  13. Genetic Counselling / Services / Education genetic counselling, education and public services.
  14. Ethical, Legal and Psychosocial Aspects in Genetics psychological, ethical and legal issues in genetics.